Repurposing avoids the long, sometimes multi-decade process of developing and approving a new drug for a specific indication, ...
The Food Allergy Fund (FAF) today convened scientists, investors, policymakers, and advocates at its annual Summit in New ...
Two approaches to AI in preclinical drug discovery are diverging, from multi-thousand GPU systems to models with only a ...
The rapid emergence of antimicrobial resistance (AMR) and zoonotic pathogens underscores the urgent need for innovative, interdisciplinary strategies to ...
Inside a lab at the Massachusetts Institute of Technology late last year, scientists gave an AI system a new task: designing entirely new molecules for potential antibiotics from scratch. Within a day ...
Drug repurposing could help find a treatment for multiple sulfatase deficiency, a rare genetic disease that currently has no ...
Researchers from Germany and Luxembourg have used AI and brain organoid models to identify two existing drugs, talarozole and sertaconazole, as potential treatments for Leigh syndrome. The approach ...
The need for medical treatments for rare diseases such as Leigh syndrome is high. However, low patient numbers make research ...
With the help of artificial intelligence, a coalition of Bay Area institutions identified 18 FDA-approved drugs that could improve the lives of those suffering from amyotrophic lateral sclerosis, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results